Related references
Note: Only part of the references are listed.The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction
Carl E. Orringer et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2021)
Coronary Artery Calcium Score-Directed Primary Prevention With Statins on the Basis of the 2018 American College of Cardiology/American Heart Association/Multisociety Cholesterol Guidelines
Jana Taron et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials
Emily Herrett et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American Individuals
Aferdita Spahillari et al.
JAMA CARDIOLOGY (2020)
HOPE for Rational Statin Allocation for Primary Prevention: A Coronary Artery Calcium Picture Is Worth 1000 Words
Carl E. Orringer et al.
MAYO CLINIC PROCEEDINGS (2020)
No-Charge Coronary Artery Calcium Screening for Cardiovascular Risk Assessment
Sadeer G. Al-Kindi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Impact of Plaque Burden Versus Stenosis on Ischemic Events in Patients With Coronary Atherosclerosis
Martin Bodtker Mortensen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects
Frances A. Wood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
Jordan Fulcher et al.
LANCET (2019)
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
Ulrich Laufs et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease
Donald M. Lloyd-Jones et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease
Holly F. Hope et al.
PLOS ONE (2019)
Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study
Christie M. Ballantyne et al.
ATHEROSCLEROSIS (2018)
Trust the Blinded Randomized Evidence That Statin Therapy Rarely Causes Symptomatic Side Effects
Richard Peto et al.
CIRCULATION (2018)
Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium Scoring
Joshua D. Mitchell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Optimizing Cholesterol Treatment in Patients With Muscle Complaints
Robert S. Rosenson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Implications of Coronary Artery Calcium Testing for Treatment Decisions Among Statin Candidates According to the ACC/AHA Cholesterol Management Guidelines A Cost-Effectiveness Analysis
Jonathan C. Hong et al.
JACC-CARDIOVASCULAR IMAGING (2017)
The Identification of Calcified Coronary Plaque Is Associated With Initiation and Continuation of Pharmacological and Lifestyle Preventive Therapies A Systematic Review and Meta-Analysis
Ankur Gupta et al.
JACC-CARDIOVASCULAR IMAGING (2017)
CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines
Amir A. Mahabadi et al.
JACC-CARDIOVASCULAR IMAGING (2017)
Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up
Antonio J. Vallejo-Vaz et al.
CIRCULATION (2017)
The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability
Robert S. Rosenson et al.
CARDIOVASCULAR DRUGS AND THERAPY (2017)
Primary Prevention With Statin Therapy in the Elderly New Meta-Analyses From the Contemporary JUPITER and HOPE-3 Randomized Trials
Paul M. Ridker et al.
CIRCULATION (2017)
Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening A Modeling Study
Diana L. Miglioretti et al.
ANNALS OF INTERNAL MEDICINE (2016)
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance The GAUSS-3 Randomized Clinical Trial
Steven E. Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People The BioImage Study
Martin Bodtker Mortensen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment
Joseph Yeboah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Statin-Associated Side Effects
Paul D. Thompson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Interpretation of the evidence for the efficacy and safety of statin therapy
Rory Collins et al.
LANCET (2016)
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
S. Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Statin-associated muscle symptoms EAS Consensus Panel paper focuses on this neglected patient group
Jane Stock
ATHEROSCLEROSIS (2015)
Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines MESA (Multi-Ethnic Study of Atherosclerosis)
Khurram Nasir et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
Jordan Fulcher et al.
LANCET (2015)
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
Frederick J. Raal et al.
LANCET (2015)
Effect of Statins on Skeletal Muscle Function
Beth A. Parker et al.
CIRCULATION (2013)
Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences
Rajiv Chowdhury et al.
EUROPEAN HEART JOURNAL (2013)
Benefits of Statins in Elderly Subjects Without Established Cardiovascular Disease A Meta-Analysis
Gianluigi Savarese et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Reduced dietary salt for the prevention of cardiovascular disease (Withdrawn
Alma J. Adler et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin users
Jerome D. Cohen et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study
Michael J. Blaha et al.
LANCET (2011)
PREVALENCE AND RISK FACTORS OF MUSCLE COMPLICATIONS SECONDARY TO STATINS
Khalid El-Salem et al.
MUSCLE & NERVE (2011)
Coronary Calcium Score Improves Classification of Coronary Heart Disease Risk in the Elderly The Rotterdam Study
Suzette E. Elias-Smale et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Efficacy of Rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins
Mamatha Gadarla et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
Haruo Nakamura et al.
LANCET (2006)
Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients -: The PRIMO study
E Bruckert et al.
CARDIOVASCULAR DRUGS AND THERAPY (2005)
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
HM Colhoun et al.
LANCET (2004)
Nonspecific medication side effects and the nocebo phenomenon
AJ Barsky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
